scorecardresearch
Thursday, March 28, 2024
Support Our Journalism
HomeIndiaHaryana minister Anil Vij on nasal oxygen support, undergoes plasma therapy

Haryana minister Anil Vij on nasal oxygen support, undergoes plasma therapy

Vij had tested positive for Covid-19 on 5 December, days after being administered the vaccine candidate Covaxin. He was shifted to PGIMS, Rohtak, Sunday night but remains stable.

Follow Us :
Text Size:

Chandigarh: Haryana Minister Anil Vij who was shifted to the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak Sunday night, after he showed ‘advanced Covid-19 symptoms’, continues to remain stable.

He is, however, on nasal oxygen support and has been administered a dose of Covid-19 plasma.

Vij, who heads the health, home and a number of other ministries, had tested positive on 5 December, some 15 days after being administered a trial dose of the Covid-19 vaccine candidate Covaxin.

He had been admitted at the Ambala Civil Hospital but was shifted to PGIMS Rohtak Sunday night.  

Dr Pushpa Dahiya, medical superintendent, PGIMS Rohtak, told ThePrint that Vij’s health was being monitored closely by a team of half a dozen doctors including a pulmonologist and an endocrinologist. The institution is also in touch with doctors at the All India Institute of Medical Sciences, New Delhi, and Medanta in Gurugram.

“The health minister was shifted to our hospital two days ago after a CT scan showed the involvement of both his lungs, one a little more than the other. Since yesterday morning we have put him on nasal oxygen,” Dahiya said. “He is comfortable and all his other parameters are fine. Yesterday, we administered Covid plasma and depending on the reports that we get in the evening today, another dose might be given.”

She added that he had already been given Remdesivir at Ambala. 


Also read: Need continued talks, long-term solutions — what experts say on farmers protest


Vij had been administered Covid vaccine

Vij had volunteered for the third phase of the Covaxin trials taking place across the country. He was among the first to be given a trial shot at a hospital in Ambala on 20 November. Vij is among almost 26,000 people across the country who are undergoing the Phase 3 trials of Covaxin, the indigenously developed vaccine candidate by Bharat Biotech.

After he was declared Covid positive, Vij said that he had been told by doctors that the antibodies would take at least a fortnight to develop from the day of the second dose being administered. He had received only the first shot. 

Without referring to Vij, Bharat Biotech had said in a statement: “COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the second dose. COVAXIN has been designed to be efficacious when subjects receive both the doses.”

Since Vij has now tested positive, he will not be able to continue with the rest of the vaccination schedule.


Also read: ‘Kisan vs Delhi’ is ‘rebellion & revolution’ for Punjab and Haryana’s singers


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular